Analyze leading players in the Veterinary Diagnostics Market Size, Share and Forecast 2025–2035 Market scaling to USD 15.9 Billion by 2035. Deep dive into competitive positioning and capital deployment.
A Market Reshaping for Tomorrow's Industry
Pets are getting more care than ever before. Pet owners want faster answers. Vets need smarter tools to deliver them.
This market is set to grow fast. It will rise from USD 6.8 Billion in 2025 to USD 15.9 Billion by 2035. That is a strong 8.9% compound annual growth rate (CAGR) from 2026 to 2035.
Report ID: HII-2E5AB5C5
For an In-depth Analysis of the Top Companies Transforming the Global Veterinary Diagnostics , and Market, .
Two forces are doing the heavy lifting. Rising spending on companion animal healthcare is adding routine tests. Connected analyzers and cloud reporting are also building steady software revenue.
Cost remains a hurdle. Advanced imaging and analyzers carry high price tags. That slows replacement cycles at small independent practices.
The market's growth shows up across three primary segments:
| Primary Segment | Growth Outlook, 2026–2035 |
|---|---|
| Veterinary Diagnostics Systems & Hardware | Steady demand from clinic and hospital upgrades |
| Veterinary Diagnostics Software & Digital Platforms | Fastest recurring revenue potential |
| Veterinary Diagnostics Integration & Services | Growing role as clinics connect their systems |
| Total Market | USD 6.8 Billion (2025) to USD 15.9 Billion (2035) |
Source: Healthcare Industry Insights Analysis, 2026
Market share is still shaped by scale and technology. Established platforms hold large revenue bases. Newer, high growth areas are pulling in fresh investment and research spending.
Zoetis Inc.
Zoetis is one of the biggest names in animal health. Its size gives it wide reach across pet clinics and farms. Its diagnostics tools sit alongside a large portfolio of medicines and vaccines.
Zoetis is pushing its digital reach through connected clinic tools. Diagnostics help vets make faster decisions. That keeps clinics tied to its wider product family.
Sources: zoetis.com (newsroom, 2025/2026).
Zoetis fits the big shift toward digital workflows. Clinics want data that flows into one system. A strong global supply base also helps during shortages. For investors, this creates value from recurring product and service sales.
IDEXX Laboratories, Inc.
IDEXX is a leader in in clinic diagnostics. Its analyzers are a common sight in veterinary hospitals worldwide. The company also runs a large reference lab network that supports its clinic tools.
IDEXX keeps investing in new analyzers and cloud reporting. Its platforms help clinics send results and track patient history. These upgrades turn one time sales into long term customer relationships.
Sources: idexx.com (investor relations, 2026).
IDEXX also plays a wide regional role. Its global footprint helps it reach clinics across many countries. Its software layer adds recurring revenue on top of hardware. This mix gives it a stable edge through 2035.
Abaxis, Inc. (a subsidiary of Zoetis Inc.)
Abaxis is known for fast, compact blood analyzers. Its systems give vets quick results right in the exam room. That speed is a major selling point for busy clinics.
The brand has built strong ties with core programs for point of care testing. Its tools fit into daily patient visits. This makes them hard to replace once a clinic adopts them.
Sources: zoetis.com (newsroom, 2025).
Abaxis now operates within the Zoetis family. That gives it access to a wider sales network. The result is deep customer loyalty and a steady flow of consumable revenue. Clinics that rely on its tools tend to stay put.
"Today marks a transformative inflection point for next generation systems. Our strategic focus accelerates the deployment of high reliability platforms engineered to outperform under complex operational environments."
Heska Corporation
Heska focuses on diagnostic instruments for animal health. Its equipment serves clinics that need reliable in house testing. Its products target practices that want to run tests on site.
Heska has pushed forward with updated analyzer technology. Its tools aim to make testing simpler for busy teams. The company also works closely with clinic partners to fit its tools into daily routines.
Sources: heska.com (newsroom, 2026).
Heska plays a useful role for smaller and mid sized practices. These clinics often feel the cost pressure most. Affordable, dependable tools help them grow their testing menus. That opens new paths to recurring supply revenue.
Neogen Corporation
Neogen builds its strength on a strong base of testing technology. Its expertise spans several testing fields. That breadth gives it a solid foundation across the testing ecosystem.
Neogen continues to upgrade its testing platforms. New tools aim to deliver faster, more accurate results. Its supply chain supports consistent product delivery across markets.
Sources: neogen.com (newsroom, 2026).
Neogen acts as a quiet enabler for the wider market. Its technology supports many testing workflows. As demand grows, its platforms help labs and clinics keep pace. This positions it well for long term growth through 2035.